First National Trust Co Buys 165 Shares of Colgate-Palmolive (NYSE:CL)

First National Trust Co grew its stake in shares of Colgate-Palmolive (NYSE:CL) by 3.1% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 5,505 shares of the company’s stock after acquiring an additional 165 shares during the period. First National Trust Co’s holdings in Colgate-Palmolive were worth $439,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. OFI Invest Asset Management bought a new stake in Colgate-Palmolive during the 3rd quarter worth approximately $25,000. Avion Wealth grew its stake in shares of Colgate-Palmolive by 78.1% in the fourth quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after purchasing an additional 175 shares during the last quarter. McGlone Suttner Wealth Management Inc. acquired a new stake in Colgate-Palmolive in the fourth quarter valued at $34,000. Kayne Anderson Rudnick Investment Management LLC raised its position in Colgate-Palmolive by 142.0% during the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock worth $35,000 after purchasing an additional 291 shares during the last quarter. Finally, West Branch Capital LLC lifted its holdings in Colgate-Palmolive by 24.0% during the 4th quarter. West Branch Capital LLC now owns 682 shares of the company’s stock worth $54,000 after buying an additional 132 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on CL shares. Raymond James upgraded Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price objective for the company in a research report on Monday, January 29th. Bank of America raised their price target on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a report on Monday, April 29th. Citigroup upped their price objective on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, April 16th. Wells Fargo & Company boosted their target price on shares of Colgate-Palmolive from $90.00 to $92.00 and gave the company an “equal weight” rating in a report on Monday, April 29th. Finally, Barclays increased their price target on Colgate-Palmolive from $84.00 to $85.00 and gave the stock an “equal weight” rating in a report on Tuesday, April 30th. Three equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $91.44.

Colgate-Palmolive Trading Down 0.0 %

NYSE CL traded down $0.03 during trading on Friday, hitting $92.88. 5,432,695 shares of the company’s stock traded hands, compared to its average volume of 4,878,342. The firm has a market cap of $76.20 billion, a P/E ratio of 29.39, a PEG ratio of 3.43 and a beta of 0.40. The stock has a fifty day moving average of $88.35 and a two-hundred day moving average of $82.21. The company has a debt-to-equity ratio of 13.21, a current ratio of 1.06 and a quick ratio of 0.28. Colgate-Palmolive has a 12-month low of $67.62 and a 12-month high of $93.25.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.82 by $0.04. The business had revenue of $5.07 billion for the quarter, compared to analyst estimates of $4.96 billion. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. Colgate-Palmolive’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same period last year, the company earned $0.73 EPS. As a group, sell-side analysts expect that Colgate-Palmolive will post 3.52 EPS for the current year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.15%. The ex-dividend date of this dividend is Friday, April 19th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio (DPR) is 63.29%.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, insider Jennifer Daniels sold 5,790 shares of the stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $83.96, for a total value of $486,128.40. Following the completion of the sale, the insider now owns 63,236 shares in the company, valued at approximately $5,309,294.56. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other news, insider Jennifer Daniels sold 5,790 shares of the company’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $83.96, for a total transaction of $486,128.40. Following the transaction, the insider now directly owns 63,236 shares of the company’s stock, valued at $5,309,294.56. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Noel R. Wallace sold 69,948 shares of the stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $84.22, for a total value of $5,891,020.56. Following the completion of the transaction, the chief executive officer now directly owns 286,881 shares in the company, valued at approximately $24,161,117.82. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 159,048 shares of company stock worth $13,336,846. 0.34% of the stock is currently owned by company insiders.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.